
Future Fields

Future Fields is a pioneering biotechnology company based in Edmonton, Alberta, Canada transforming the landscape of protein production through its proprietary EntoEngine™ platform. Founded in 2018, the company is the first to use genetically engineered fruit flies (Drosophila melanogaster) for the commercial manufacturing of recombinant protein. This novel approach offers a sustainable, scalable, and cost-effective alternative to traditional bioreactor-based systems. Future Fields’ platform supports applications across pharmaceuticals, cellular agriculture, and food tech, enabling the production of complex proteins with reduced environmental impact.